Cargando…
Promoter Methylation of QKI as a Potential Specific Biomarker for Early Detection of Colorectal Cancer
Early and specific detection of cancer provides an opportunity for appropriate treatment. Although studies have suggested that QKI is a tumor suppressor gene, no studies have evaluated the diagnostic utility of QKI methylation in colorectal cancer (CRC). Here, we evaluated the methylation status of...
Autores principales: | Zhang, Lei, Li, Dapeng, Gao, Lijing, Fu, Jinming, Sun, Simin, Huang, Hao, Zhang, Ding, Jia, Chenyang, Zheng, Ting, Cui, Binbin, Liu, Yanlong, Zhao, Yashuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395658/ https://www.ncbi.nlm.nih.gov/pubmed/36017498 http://dx.doi.org/10.3389/fgene.2022.928150 |
Ejemplares similares
-
Integrative Analysis of Identifying Methylation-Driven Genes Signature Predicts Prognosis in Colorectal Carcinoma
por: Huang, Hao, et al.
Publicado: (2021) -
Discovery and validation of tissue-specific DNA methylation as noninvasive diagnostic markers for colorectal cancer
por: Li, Dapeng, et al.
Publicado: (2022) -
SCTR hypermethylation is a diagnostic biomarker in colorectal cancer
por: Li, DaPeng, et al.
Publicado: (2020) -
Pan‐cancer analysis of genome‐wide methylation profiling discover type‐specific markers targeting circulating free DNA for the detection of colorectal cancer
por: Zhang, Lei, et al.
Publicado: (2023) -
Development and validation of prognostic nomograms based on De Ritis ratio and clinicopathological features for patients with stage II/III colorectal cancer
por: Fu, Jinming, et al.
Publicado: (2023)